Related Experiment Video
Updated: Jan 10, 2026
Disorders of Erythrocytes
Insights from transgenic mouse models of ERBB2-induced breast cancer
Josie Ursini-Siegel1, Babette Schade, Robert D Cardiff
1Departments of Medicine and Biochemistry, McGill University, Montreal, Quebec, Canada.
Abstract:
One-third of patients with breast cancer overexpress the ERBB2 receptor tyrosine kinase, which is associated not only with a more aggressive phenotype but also reduced responsiveness to hormonal therapies. Over the past two decades, many ERBB2 mouse models for breast cancer have conclusively shown that this receptor has a causal role in breast cancer development. These mouse models have also enabled the mechanisms controlling tumour growth, angiogenesis, metastasis, dormancy and recurrence in ERBB2-positive breast cancer to be elucidated. In addition, a mouse model has recently been described that accurately recapitulates many of the hallmarks associated with the early stages of the human disease.
Insights
ERBB2-positive breast cancer is aggressive and resistant to hormonal therapies. Mouse models have been crucial in understanding ERBB2
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- One-third of breast cancers overexpress the ERBB2 receptor tyrosine kinase.
- ERBB2 overexpression is linked to aggressive disease and poor response to hormonal therapies.
Purpose of the Study:
- To review the role of ERBB2 in breast cancer development and progression.
- To highlight the utility of ERBB2 mouse models in elucidating cancer mechanisms.
Main Methods:
- Review of established ERBB2 mouse models for breast cancer.
- Analysis of mechanisms controlling tumor growth, angiogenesis, metastasis, dormancy, and recurrence.
Main Results:
- ERBB2 mouse models have confirmed the receptor's causal role in breast cancer.
- These models have elucidated key biological processes in ERBB2-positive breast cancer.
- A recent model accurately recapitulates early-stage human disease hallmarks.
Conclusions:
- ERBB2 plays a critical role in breast cancer pathogenesis.
- ERBB2 mouse models are invaluable tools for understanding ERBB2-driven breast cancer.
- Further research using these models can inform therapeutic strategies.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:38Mitogens and the Cell Cycle